Carlayne Jackson Selected Research

reldesemtiv

1/2022	Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial.
1/2021	A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlayne Jackson Research Topics

Disease

4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2022 - 11/2019
3	Myasthenia Gravis 01/2020 - 09/2003
1	Cognitive Dysfunction 01/2022
1	Disease Progression 01/2022
1	Fatigue 01/2021
1	Nausea 01/2021
1	Guillain-Barre Syndrome 01/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2015

Drug/Important Bio-Agent (IBA)

2	reldesemtivIBA 01/2022 - 01/2021
1	ursodoxicoltaurineIBA 05/2022
1	4-phenylbutyric acid (Buphenyl)FDA Link 05/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	AgrinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	EdaravoneIBA 11/2019
1	SteroidsIBA 07/2016
1	Methotrexate (Mexate)FDA LinkGeneric 07/2016
1	GangliosidesIBA 01/2015
1	AntibodiesIBA 01/2015
1	AutoantigensIBA 09/2003
1	Cholinergic ReceptorsIBA 09/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2003

Therapy/Procedure

1	Tracheostomy 05/2022
1	Therapeutics 01/2020
1	Activities of Daily Living (ADL) 07/2016